Clinical Trial Update: Ranibizumab "Treat and Extend" in Diabetic Macular Edma [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluates a treat-and-extend dosing strategy of ranibizumab for diabetic macular edema; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Diabetic Macular Edema | Phase 4 | Status: COMPLETED